… Author links open overlay panel Naveed Z. Janjua 1 2 , Mei Chong 1 , Margot Kuo 1 , Ryan
Woods 3 , Jason Wong 1 2 , Eric M. Yoshida 4 , Morris Sherman 5 , Zahid A. Butt 1 2 , Hasina …

Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the …

Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (…

Objective. To identify maternal and early childhood risk factors for obesity and overweight
among children at age 5 in the state of Alabama. Methods. We recruited 740 mothers during …

Background Influenza vaccine effectiveness (VE) is generally interpreted in the context of
vaccine match/mismatch to circulating strains with evolutionary drift in the latter invoked to …

Background Population-level monitoring of hepatitis C virus (HCV) infected people across
the cascade of care identifies gaps in access and engagement in care and treatment. We …

Background Clinical trials show high efficacy of sofosbuvir/velpatasvir (SOF/VEL), but there
are limited data from “real-world” settings. We aimed to evaluate SOF/VEL effectiveness for …

Background To determine the utility of admission laboratory markers in the assessment and
prognostication of coronavirus disease‐2019 (COVID‐19), a systematic review and meta‐…

Importance SARS-CoV-2 infection may lead to acute and chronic sequelae. Emerging evidence
suggests a higher risk of diabetes after infection, but population-based evidence is still …

Background Since the release of the first global hepatitis elimination targets in 2016, and until
the COVID-19 pandemic started in early 2020, many countries and territories were making …